Last update 23 Jan 2025

CISH inactivated tumor infiltrating lymphocyte cell therapy (Intima Bioscience)

Overview

Basic Info

Drug Type
TIL therapy
Synonyms
Tumor infiltrating lymphocyte cell therapy Intima Bioscience
Target-
Mechanism
Immunologic cytotoxicity, T lymphocyte replacements
Therapeutic Areas
NeoplasmsDigestive System DisordersEndocrinology and Metabolic Disease
Active Indication
Colonic CancerEsophageal CarcinomaGallbladder Carcinoma+ [3]
Inactive Indication-
Originator Organization
Intima Bioscience, Inc.Intima Bioscience, Inc.
Active Organization
Intima Bioscience, Inc.Intima Bioscience, Inc.
Inactive Organization-
Drug Highest PhasePhase 1/2
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with CISH inactivated tumor infiltrating lymphocyte cell therapy (Intima Bioscience)
NCT04426669
/ Active, not recruitingPhase 1/2
A Phase I/II Trial in Patients With Metastatic Gastrointestinal Epithelial Cancer Administering Tumor-Infiltrating Lymphocytes in Which the Gene Encoding CISH Was Inactivated Using the CRISPR/Cas9 System
100 Clinical Results associated with CISH inactivated tumor infiltrating lymphocyte cell therapy (Intima Bioscience)
Login to view more data
100 Translational Medicine associated with CISH inactivated tumor infiltrating lymphocyte cell therapy (Intima Bioscience)
Login to view more data
100 Patents (Medical) associated with CISH inactivated tumor infiltrating lymphocyte cell therapy (Intima Bioscience)
Login to view more data
100 Deals associated with CISH inactivated tumor infiltrating lymphocyte cell therapy (Intima Bioscience)
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Colonic CancerPhase 2
US
Intima Bioscience, Inc.Intima Bioscience, Inc.
15 May 2020
Esophageal CarcinomaPhase 2
US
Intima Bioscience, Inc.Intima Bioscience, Inc.
15 May 2020
Gallbladder CarcinomaPhase 2
US
Intima Bioscience, Inc.Intima Bioscience, Inc.
15 May 2020
Metastatic Digestive System CarcinomaPhase 2
US
Intima Bioscience, Inc.Intima Bioscience, Inc.
15 May 2020
Pancreatic CancerPhase 2
US
Intima Bioscience, Inc.Intima Bioscience, Inc.
15 May 2020
Stomach CancerPhase 2
US
Intima Bioscience, Inc.Intima Bioscience, Inc.
15 May 2020
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free